Nanvuranlat

DB18250InvestigationalSmall molecule

Nanvuranlat: Overview.

Mechanism: Pharmacologically active on Large neutral amino acids transporter small subunit 1
Curator reviewed
Formula / weight: C₂₃H₁₉Cl₂N₃O₄ · 472.32 g/mol (avg)
Also known as: (2s)-2-amino-3-(4-((5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy)-3,5-dichloro-phenyl)propanoic acid · L-tyrosine, o-((5-amino-2-phenyl-7-benzoxazolyl)methyl)-3,5-dichloro- · O-((5-amino-2-phenyl-1,3-benzoxazol-7-yl)methyl)-3,5- dichloro-l-tyrosine
Code names: JPH-203 · KYT-0353

Resolves to

Compound

Structure

InChIKeyXNRZJPQTMQZBCE-SFHVURJKSA-NSMILESN[C@@H](CC1=CC(Cl)=C(OCC2=C3OC(=NC3=CC(N)=C2)C2=CC=CC=C2)C(Cl)=C1)C(O)=O

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nanvuranlat, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.